EcoDrugPlus

Presenilin Enhancer, Gamma-Secretase Subunit

Ensembl ID : ENSORLG00000006446
Gene Symbol: PSENEN
4 Cross references
183 Possible Orthologues:

Progesterone Receptor

Ensembl ID : ENSORLG00000002651
Gene Symbol: PGR
3 Cross references
193 Possible Orthologues:

Prostaglandin D2 Receptor 2

Ensembl ID : ENSORLG00000025625
Gene Symbol: PTGDR2
4 Cross references
134 Possible Orthologues:

Prostaglandin D2 Receptor 2-Like

Ensembl ID : ENSORLG00000014156
Gene Symbol: LOC110013710
3 Cross references
143 Possible Orthologues:

Prostaglandin E Receptor 2a (Subtype Ep2)

Ensembl ID : ENSORLG00000003901
Gene Symbol: PTGER2A
4 Cross references
202 Possible Orthologues:

Prostaglandin E Receptor 3

Ensembl ID : ENSORLG00000022393
Gene Symbol: PTGER3
4 Cross references
194 Possible Orthologues:

Prostaglandin E Receptor 4 (Subtype Ep4) A

Ensembl ID : ENSORLG00000023313
Gene Symbol: PTGER4A
4 Cross references
202 Possible Orthologues:

Prostaglandin E Receptor 4 (Subtype Ep4) B

Ensembl ID : ENSORLG00000003829
Gene Symbol: PTGER4B
3 Cross references
201 Possible Orthologues:

Prostaglandin E2 Receptor Ep1 Subtype

Ensembl ID : ENSORLG00000014518
Gene Symbol: LOC101172795
4 Cross references
167 Possible Orthologues:

Prostaglandin E2 Receptor Ep1 Subtype

Ensembl ID : ENSORLG00000016366
Gene Symbol: LOC101160911
4 Cross references
164 Possible Orthologues:

Prostaglandin F Receptor (Fp)

Ensembl ID : ENSORLG00000024637
Gene Symbol: PTGFR
4 Cross references
195 Possible Orthologues:

Prostaglandin G/h Synthase 1

Ensembl ID : ENSORLG00000005095
Gene Symbol: LOC101161174
4 Cross references
182 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).